San Antonio, TX, United States of America

Susan E Hamilton

This inventor holds 1 USPTO granted patent. Top assignee: Bionumerik Pharmaceuticals, Inc.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Susan E Hamilton in Diabetes Treatment

Introduction

Susan E Hamilton is a notable inventor based in San Antonio, TX (US). She has made significant contributions to the field of diabetes treatment through her innovative approaches. Her work focuses on reducing the toxicity associated with diabetes treatments, which is a critical area of research.

Latest Patents

Susan holds a patent for "Methods and formulations for reducing toxicity associated with diabetes treatments." This patent describes formulations and methods aimed at minimizing the unwanted toxicity and complications that can arise from treatments for diabetes mellitus. The formulations include co-formulations of an anti-diabetic agent and a toxicity-reducing agent, as detailed in the specification. The methods involve administering effective amounts of both the anti-diabetic agent and the toxicity-reducing agent to safely treat diabetic patients.

Career Highlights

Susan is currently associated with Bionumerik Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has the potential to significantly improve the quality of life for individuals living with diabetes.

Collaborations

Some of her notable coworkers include Aulma Parker and Frederick H Hausheer, who contribute to her research endeavors.

Conclusion

Susan E Hamilton's innovative work in diabetes treatment exemplifies the importance of reducing toxicity in medical therapies. Her contributions are paving the way for safer and more effective treatments for diabetic patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…